Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab. [electronic resource]
- Annals of oncology : official journal of the European Society for Medical Oncology Apr 2016
- 732-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1569-8041
10.1093/annonc/mdw016 doi
Adolescent Adult Aged Aged, 80 and over Antibodies, Monoclonal--administration & dosage Biomarkers, Tumor--blood Disease-Free Survival Female Humans Ipilimumab Italy Lymphocyte Count Lymphocytes--pathology Male Melanoma--blood Middle Aged Neutrophils--pathology Prognosis